GLOBAL X ETFs ICAV

(an umbrella fund with segregated liability between sub-funds)

10 Earlsfort Terrace

Dublin 2 D02 T380

Ireland

This document is important and requires your immediate attention. If you are in any doubt as to the action you should take, you should seek advice from your investment consultant or other professional advisors. This document has not been reviewed by the Central Bank of Ireland (the "Central Bank").

If you have sold or transferred all of your shares in Global X Agtech & Food Innovation UCITS ETF, Global X Blockchain UCITS ETF, Global X Wind Energy UCITS ETF or Global X Solar UCITS ETF (each a "Fund", and together the "Funds"), please pass this document at once to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee as soon as possible.

Capitalised terms used herein shall bear the same meaning as defined in the prospectus of Global X ETFs ICAV (the "ICAV) dated 6 May 2021, as amended by addenda thereto dated 13 December 2021 and 13 May 2022 respectively, (the "Prospectus") and the supplement in respect of each Fund (the "Supplement"). Copies of the Prospectus and Supplement are available upon request during normal business hours from the registered office of the ICAV.

15 November 2022

RE:   Notification of amendments to the investment policy of each of the Funds.

Dear Investors,

The ICAV is an open-ended investment vehicle with variable capital organised under the laws of Ireland and is authorised by the Central Bank pursuant to the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011, as amended.  The Funds are sub-funds of the ICAV.

The Supplements disclose that the Funds, by holding each equity security in approximately the same proportion as its weighting in the Index, in accordance with the investment policy, may have exposure to, or invest up to, 20% of the Net Asset Value of the Fund in stocks issued by the same body.  It is proposed that the Supplements be updated to reflect the proposal to allow this 20% limit to be raised to 35% of the Net Asset Value of the Funds for a single issuer in exceptional market conditions, which may include the dominance of a particular issuer in the relevant market.

It is proposed that the changes to the Supplements outlined above will take effect on, or around, 30 November 2022, subject to the approval of the Central Bank.

Should you have any questions relating to the changes detailed above, you should contact your local

agent, or (if none) Global X ETFs on +44 (0)20 4529 2551 or [email protected], or alternatively you should contact your investment consultant, tax adviser and/or legal adviser as appropriate.

Yours faithfully,

_______________

For and on behalf of

Global X ETFs ICAV

Registered Office: as above

Registration Number: C435449

Directors: Feargal Dempsey, Mary Canning and Luis Berruga (USA)